Antibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MAB17291 - Provider product page
- Provider
- R&D Systems
- Product name
- Anti-Human/Mouse TREM-2 Monoclonal Antibody (Clone 237920)
- Antibody type
- Monoclonal
- Antigen
- Mouse myeloma cell line NS0-derived recombinant mouse TREM-2, extracellular domain
- Description
- Protein A or G purified from hybridoma culture supernatant
- Reactivity
- Human, Mouse
- Host
- Rat
- Antigen sequence
Q99NH8
- Isotype
- IgG
- Vial size
- 500 µg
Submitted references Human Induced Pluripotent Stem Cell-Derived Microglia-Like Cells Harboring TREM2 Missense Mutations Show Specific Deficits in Phagocytosis.
Interleukin-2 improves amyloid pathology, synaptic failure and memory in Alzheimer's disease mice.
A split-luciferase complementation, real-time reporting assay enables monitoring of the disease-associated transmembrane protein TREM2 in live cells.
TREM-2 promotes macrophage survival and lung disease after respiratory viral infection.
Triggering receptor expressed on myeloid cells 2 (TREM2) deficiency attenuates phagocytic activities of microglia and exacerbates ischemic damage in experimental stroke.
Nuclear receptors license phagocytosis by trem2+ myeloid cells in mouse models of Alzheimer's disease.
Garcia-Reitboeck P, Phillips A, Piers TM, Villegas-Llerena C, Butler M, Mallach A, Rodrigues C, Arber CE, Heslegrave A, Zetterberg H, Neumann H, Neame S, Houlden H, Hardy J, Pocock JM
Cell reports 2018 Aug 28;24(9):2300-2311
Cell reports 2018 Aug 28;24(9):2300-2311
Interleukin-2 improves amyloid pathology, synaptic failure and memory in Alzheimer's disease mice.
Alves S, Churlaud G, Audrain M, Michaelsen-Preusse K, Fol R, Souchet B, Braudeau J, Korte M, Klatzmann D, Cartier N
Brain : a journal of neurology 2017 Mar 1;140(3):826-842
Brain : a journal of neurology 2017 Mar 1;140(3):826-842
A split-luciferase complementation, real-time reporting assay enables monitoring of the disease-associated transmembrane protein TREM2 in live cells.
Varnum MM, Clayton KA, Yoshii-Kitahara A, Yonemoto G, Koro L, Ikezu S, Ikezu T
The Journal of biological chemistry 2017 Jun 23;292(25):10651-10663
The Journal of biological chemistry 2017 Jun 23;292(25):10651-10663
TREM-2 promotes macrophage survival and lung disease after respiratory viral infection.
Wu K, Byers DE, Jin X, Agapov E, Alexander-Brett J, Patel AC, Cella M, Gilfilan S, Colonna M, Kober DL, Brett TJ, Holtzman MJ
The Journal of experimental medicine 2015 May 4;212(5):681-97
The Journal of experimental medicine 2015 May 4;212(5):681-97
Triggering receptor expressed on myeloid cells 2 (TREM2) deficiency attenuates phagocytic activities of microglia and exacerbates ischemic damage in experimental stroke.
Kawabori M, Kacimi R, Kauppinen T, Calosing C, Kim JY, Hsieh CL, Nakamura MC, Yenari MA
The Journal of neuroscience : the official journal of the Society for Neuroscience 2015 Feb 25;35(8):3384-96
The Journal of neuroscience : the official journal of the Society for Neuroscience 2015 Feb 25;35(8):3384-96
Nuclear receptors license phagocytosis by trem2+ myeloid cells in mouse models of Alzheimer's disease.
Savage JC, Jay T, Goduni E, Quigley C, Mariani MM, Malm T, Ransohoff RM, Lamb BT, Landreth GE
The Journal of neuroscience : the official journal of the Society for Neuroscience 2015 Apr 22;35(16):6532-43
The Journal of neuroscience : the official journal of the Society for Neuroscience 2015 Apr 22;35(16):6532-43
No comments: Submit comment
No validations: Submit validation data